We studied the expression and distribution of the microtubule-severing enzyme spastin in 3 human glioblastoma cell lines (U87MG, U138MG, and T98G) and in clinical tissue samples representative of all grades of diffuse astrocytic gliomas (n = 45). In adult human brains, spastin was distributed predominantly in neuronsand neuropil puncta and, to a lesser extent, in glia. Compared with normal mature brain tissues, spastin expression and cellular distribution were increased in neoplastic glial phenotypes, especiallyin glioblastoma (p < 0.05 vs low-grade diffuse astrocytomas). Overlapping punctate and diffuse patterns of localization wereidentified in tumor cells in tissues and in interphase and mitotic cells ofglioblastoma cell lines. There was enrichment of spastin in the leading edges of cells in T98G glioblastoma cell cultures and in neoplastic cell populations in tumor specimens. Real-time polymerase chain reaction and immunoblotting experiments revealed greater levels of spastin messenger RNA and protein expression in theglioblastoma cell lines versus normal human astrocytes. Functional experiments indicated that spastin depletion resulted in reduced cell motility and higher cell proliferation of T98G cells. Toour knowledge, this is the first report of spastin involvement incellmotility. Collectively, our results indicate that spastinexpression in glioblastomas might be linked to tumor cell motility, migration, and invasion.

Department of the Biology of Cytoskeleton Institute of Molecular Genetics Czech Republic

Zobrazit více v PubMed

Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479–89. PubMed

Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol. 1998;10:123–30. PubMed

Pasquier E, Kavallaris M. Microtubules: a dynamic target in cancer therapy. IUBMB Life. 2008;60:165–70. PubMed

Dumontet C, Jordan MA. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov. 2010;9:790–803. PubMed PMC

Baas PW, Karabay A, Qiang L. Microtubules cut and run. Trends Cell Biol. 2005;15:518–24. PubMed

Whipple RA, Cheung AM, Martin SS. Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment. Exp Cell Res. 2007;313:1326–36. PubMed PMC

Schoumacher M, Goldman RD, Louvard D, et al. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol. 2010;189:541–56. PubMed PMC

Liaw TY, Chang MH, Kavallaris M. The cytoskeleton as a therapeutic target in childhood acute leukemia: obstacles and opportunities. Curr Drug Targets. 2007;8:739–49. PubMed

Ferlini C, Raspaglio G, Cicchillitti L, et al. Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work? Curr Cancer Drug Targets. 2007;7:704–12. PubMed

Katsetos CD, Dráberová E, Legido A, et al. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III β-tubulin. J Cell Physiol. 2009;221:505–13. PubMed

Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer. 2010;10:194–204. PubMed

Régina A, Demeule M, Ché C, et al. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol. 2008;155:185–97. PubMed PMC

Mielke S, Sparreboom A, Mross K. Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. Eur J Cancer. 2006;42:24–30. PubMed

Richter-Landsberg C. The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease. J Mol Neurosci. 2008;35:55–63. PubMed

Shi J, Orth JD, Mitchison T. Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res. 2008;68:3269–76. PubMed

Hornick JE, Karanjeet K, Collins ES, et al. Kinesins to the core: The role of microtubule-based motor proteins in building the mitotic spindle midzone. Semin Cell Dev Biol. 2010;21:290–9. PubMed PMC

Baas PW, Sudo H. More microtubule severing proteins: More microtubules. Cell Cycle. 2010;9:2271–4. PubMed

Claudiani P, Riano E, Errico A, et al. Spastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus. Exp Cell Res. 2005;309:358–69. PubMed

White SR, Evans KJ, Lary J, et al. Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severing. J Cell Biol. 2007;176:995–1005. PubMed PMC

Svenson IK, Ashley-Koch AE, Gaskell PC, et al. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet. 2001;68:1077–85. PubMed PMC

Salinas S, Carazo-Salas RE, Proukakis C, et al. Human spastin has multiple microtubule-related functions. J Neurochem. 2005;95:1411–20. PubMed

Solowska JM, Morfini G, Falnikar A, et al. Quantitative and functional analyses of spastin in the nervous system: implications for hereditary spastic paraplegia. J Neurosci. 2008;28:2147–57. PubMed PMC

Hazan J, Fonknechten N, Mavel D, et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet. 1999;23:296–303. PubMed

Wharton SB, McDermott CJ, Grierson AJ, et al. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J Neuropathol Exp Neurol. 2003;62:1166–77. PubMed

Ma DL, Chia SC, Tang YC, et al. Spastin in the human and mouse central nervous system with special reference to its expression in the hippocampus of mouse pilocarpine model of status epilepticus and temporal lobe epilepsy. Neurochem Int. 2006;49:651–64. PubMed

Encinas M, Iglesias M, Liu Y, et al. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem. 2000;75:991–1003. PubMed

Dráberová E, Del Valle L, Gordon J, et al. Class III β-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J Neuropathol Exp Neurol. 2008;67:341–54. PubMed

Viklický V, Dráber P, Hasek J, et al. Production and characterization of a monoclonal antitubulin antibody. Cell Biol Int Rep. 1982;6:725–31. PubMed

Dráber P, Dráberová E, Zicconi D, et al. Heterogeneity of microtubules recognized by monoclonal antibodies to α-tubulin. Eur J Cell Biol. 1986;41:82–8. PubMed

Dráber P, Dráberová E, Viklický V. Immunostaining of human spermatozoa with tubulin domain-specific monoclonal antibodies. Recognition of a unique β-tubulin epitope in the sperm head. Histochemistry. 1991;95:519–24. PubMed

Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5. PubMed

Dráber P, Lagunowich LA, Dráberová E, et al. Heterogeneity of tubulin epitopes in mouse fetal tissues. Histochemistry. 1988;89:485–92. PubMed

Dráberová E, Dráber P. A microtubule-interacting protein involved in coalignment of vimentin intermediate filaments with microtubules. J Cell Sci. 1993;106:1263–73. PubMed

Soile P. Morphological Image Analysis. 2. Berlin: Springer; 2003.

Katsetos CD, Del Valle L, Geddes JF, et al. Aberrant localization of the neuronal class III β-tubulin in astrocytomas. Arch Pathol Lab Med. 2001;125:613–24. PubMed

Katsetos CD, Reddy G, Dráberová E, et al. Altered cellular distribution and subcellular sorting of γ-tubulin in diffuse astrocytic gliomas and human glioblastoma cell lines. J Neuropathol Exp Neurol. 2006;65:465–77. PubMed

Katsetos CD, Dráberová E, Šmejkalová B, et al. Class III β-tubulin and γ-tubulin are co-expressed and form complexes in human glioblastoma cells. Neurochem Res. 2007;32:1387–98. PubMed

Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109. PubMed PMC

Fleiss JG. Statistical Methods for Rates and Proportions. New York, NY: Wiley; 1981. pp. 225–32.

Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74. PubMed

Trotta N, Orso G, Rossetto MG, et al. The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr Biol. 2004;14:1135–47. PubMed

Quick Q, Skalli O. α-Actinin 1 and α-actinin 4: Contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells. Exp Cell Res. 2010;316:1137–47. PubMed

Pan Y, Jing R, Pitre A, et al. Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton. FASEB J. 2008;22:3196–3206. PubMed PMC

Berens ME, Beaudry C. Radial monolayer cell migration assay. Methods Mol Med. 2004:219–24. PubMed

Zhang D, Grode KD, Stewman SF, et al. Drosophila katanin is a microtubule depolymerase that regulates cortical-microtubule plus-end interactions and cell migration. Nature Cell Biol. 2011;13:361–70. PubMed PMC

Giese A, Bjerkvig R, Berens ME, et al. Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21:1624–36. PubMed

Berens ME, Giese A. …those left behind. Biology and oncology of invasive glioma cells. Neoplasia. 1999;1:208–19. PubMed PMC

Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer. 2002;2:815–25. PubMed

Ahmad FJ, Yu W, McNally FJ, et al. An essential role for katanin in severing microtubules in the neuron. J Cell Biol. 1999;145:305–15. PubMed PMC

Yu W, Ahmad FJ, Baas PW. Microtubule fragmentation and partitioning in the axon during collateral branch formation. J Neurosci. 1994;14:5872–84. PubMed PMC

Dent EW, Callaway JL, Szebenyi G, et al. Reorganization and movement of microtubules in axonal growth cones and developing interstitial branches. J Neurosci. 1999;19:8894–8908. PubMed PMC

Errico A, Claudiani P, D’Addio M, et al. Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum Mol Genet. 2004;13:2121–32. PubMed

Roll-Mecak A, Vale RD. Making more microtubules by severing: a common theme of noncentrosomal microtubule arrays? J Cell Biol. 2006;175:849–51. PubMed PMC

Roll-Mecak A, McNally FJ. Microtubule-severing enzymes. Curr Opin Cell Biol. 2010;22:96–103. PubMed PMC

Katsetos CD, Dráberová E, Legido A, et al. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. γ-Tubulin. J Cell Physiol. 2009;221:514–20. PubMed

Cho EH, Whipple RA, Matrone MA, et al. Delocalization of γ-tubulin due to increased solubility in human breast cancer cell lines. Cancer Biol Ther. 2010;9:66–76. PubMed PMC

Joshi HC, Palacios MJ, McNamara L, et al. γ-Tubulin is a centrosomal protein required for cell cycle-dependent microtubule nucleation. Nature. 1992;356:80–3. PubMed

Zheng Y, Wong ML, Alberts B, et al. Nucleation of microtubule assembly by a γ-tubulin-containing ring complex. Nature. 1995;378:578–83. PubMed

Chabin-Brion K, Marceiller J, Perez F, et al. The Golgi complex is a microtubule- organizing organelle. Mol Biol Cell. 2001;12:2047–60. PubMed PMC

Macurek L, Dráberová E, Richterová V, et al. Regulation of microtubule nucleation in differentiating embryonal carcinoma cells by complexes of membrane-bound γ-tubulin with Fyn kinase and phosphoinositide 3-kinase. Biochem J. 2008;416:421–30. PubMed

Biology of Glioblastoma Multiforme-Exploration of Mitotic Catastrophe as a Potential Treatment Modality